Corrigenda
Author(s) -
Karen K. Winer,
Bo Zhang,
Joseph A. Shrader,
Donna Peterson,
Michaele Smith,
Paul S. Albert,
Gordon B. Cutler
Publication year - 2011
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2011-1908
Subject(s) - hypercalciuria , medicine , parathyroid hormone , endocrinology , urine , bone remodeling , hypoparathyroidism , calcium , vitamin d and neurology , crossover study , placebo , alternative medicine , pathology
Vitamin D therapy for hypoparathyroidism does not restore PTH-dependent renal calcium reabsorption, which can lead to renal damage. An alternative approach, PTH 1-34 administered twice daily, provides acceptable long-term treatment but is associated with nonphysiological serum calcium fluctuation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom